- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03390881
Use of Breath Acetone aa a Marker of Energy Balance (ACEX)
Assessment of the Validity of Breath Acetone Concentration as a Bio-marker of Instantaneous Energy Balance in Healthy Subjects
Study Overview
Status
Intervention / Treatment
Detailed Description
Each participant will be studied on three occasions, separated by 1-4 weeks. Each evaluation will consist in the same set of metabolic measurements, but will be performed fasting or during administration of a 70% fat or 70% carbohydrate liquid diet, according to a randomized order.
On each occasion, subjects will consume a standardized dinner the day before the experiment. They will remain fasted since 10 pm until the test day.
On the day of the experiments, one venous cannula will be inserted into a forearm vein for the collection of blood samples. An indirect calorimetry (measurement of respiratory gas exchanges using a ventilated canopy at rest, or a face mask during exercise) will be performed throughout the 6-hour test to measure energy expenditure and net substrate oxidation rate. Blood samples will be obtained every 60 min for the measurement of plasma glucose, insulin, free fatty acids, and beta-hydroxybutyrate concentrations. Breath samples will be also collected every 60 min (in 500 ml sampling bag) for the measurement of breath acetone concentration using a novel gas analyzer based on infrared laser spectroscopy.
Measurements will be done during 3 consecutive periods:
- 0-120 min: Fast + Rest: subjects will remain lying in bed in fasting conditions (negative energy balance).
- 120-360 min: Fed + Rest: subjects will remain in bed in a fasting state (C) or will receive every hour a liquid meal containing either 70% fat, 15% carbohydrate and 15% protein (Fat), or 70% carbohydrate, 15% fat and 15% protein (Sugar), corresponding to 1.5 X hourly resting energy requirement (positive energy balance).
- 360-480 min: Fed + Exercise: subjects will be transferred to an ergometric bicycle and will be asked to bike at a power output of 25 W [i.e. increasing total energy expenditure to ca. 2 time resting energy expenditure (negative energy balance)].
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lausanne, Switzerland, 1005
- University of Lausanne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI 19.5-29.9 kg/m2,
- Healthy
Exclusion Criteria:
- any known disease (with the exception of allergies);
- consumption of alcohol > 40 g/day;
- any current drug treatment (with the exception of contraceptive agents, antihistaminergic drugs for allergies, or multivitamin supplementations),
- history of lactose intolerance,
- history of exercise intolerance.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fasting condition
Effects of cumulated negative energy balance (fasting over 480 min) on breath acetone changes
|
Subjects will fast over the whole experimental period (480 min)
|
|
Active Comparator: Sugar condition
Effects of sugar consumption on breath acetone changes
|
After a 2-h fasting state, subjects will ingest every hour a drink containing 70% carbohydrate, 15% fat and 15% protein and providing 1.5 X hourly resting energy requirement.
|
|
Active Comparator: Fat condition
Effects of fat consumption on breath acetone changes
|
After a 2-h fasting state, subjects will ingest every hour a drink containing 70% fat, 15% carbohydrate and 15% protein and providing 1.5 X hourly resting energy requirement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Breath acetone
Time Frame: Every 60 min from 0 to 420 min
|
Changes in breath acetone concentrations in conditions of positive vs. negative energy balance.
|
Every 60 min from 0 to 420 min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma parameters
Time Frame: Every 60 min from 0 to 420 min
|
Relationship between breath acetone and plasma beta-hydroxybutyrate, glucose, free fatty acids and insulin concentrations
|
Every 60 min from 0 to 420 min
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2016-01740
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fasting
-
University of BariCompleted
-
University of GuelphCompletedRamadan FastingCanada
-
University of ChileAgencia Nacional de Investigación y DesarrolloCompletedIntermittent Fasting in Shift-workChile
-
Charite University, Berlin, GermanySoftware AG Stiftung; Eden Stiftung; Reformhaus StiftungEnrolling by invitation
-
Sanliurfa Education and Research HospitalEnrolling by invitation
-
University of California, San DiegoRecruitingDepression - Major Depressive DisorderUnited States
-
King Faisal UniversitySaudi Food and Drug AuthorityRecruitingDietary Intervention | Glycemic Response; Satiety | Postprandial Glucose | Fasting, Time RestrictedSaudi Arabia
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Cedars-Sinai Medical Center; Alaska Native Tribal... and other collaboratorsNot yet recruiting
-
University of UtahTerminatedCancer PreventionUnited States
-
USDA, Western Human Nutrition Research CenterUniversity of California, DavisCompletedCardiovascular Risk Factor | Athletic Performance | Fasting | Resting Energy Expenditure | Intermittent FastingUnited States
Clinical Trials on Fasting condition
-
University of British ColumbiaRecruitingGlucose Tolerance | Fasting | Immune FunctionCanada
-
UCB Biopharma SRLCompleted
-
NVP HealthcareCompletedLow Back PainKorea, Republic of
-
Aelis FarmaNational Institute on Drug Abuse (NIDA)TerminatedMarijuana AbuseUnited States
-
GeropharmCompletedBioequivalenceRussian Federation
-
GeropharmCompleted
-
Kasr El Aini HospitalCompleted
-
UMC UtrechtDutch Heart FoundationNot yet recruitingHeart Failure NYHA Class II | Heart Failure NYHA Class III
-
Cardenal Herrera UniversityCompletedChronic Low-back Pain (cLBP)Spain
-
Rutgers, The State University of New JerseyRecruitingAggression | Problem Behavior | Self InjuryUnited States